AbbVie
ABBV
#25
Rank
NZ$914.04 B
Marketcap
NZ$517.11
Share price
-2.33%
Change (1 day)
25.13%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : NZ$254.93 Billion

According to AbbVie's latest financial reports the company's total liabilities are NZ$254.93 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AbbVie - Total liabilities on balance sheet (from 2011 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31NZ$236.87 B1.36%
2024-12-31NZ$233.69 B18.88%
2023-12-31NZ$196.57 B2.71%
2022-12-31NZ$191.39 B-0.28%
2021-12-31NZ$191.92 B0.74%
2020-12-31NZ$190.52 B31.89%
2019-12-31NZ$144.45 B42.92%
2018-12-31NZ$101.07 B9.28%
2017-12-31NZ$92.49 B4.24%
2016-12-31NZ$88.73 B23.67%
2015-12-31NZ$71.74 B118.13%
2014-12-31NZ$32.89 B9.4%
2013-12-31NZ$30.06 B4.6%
2012-12-31NZ$28.74 B195.59%
2011-12-31NZ$9.72 B38.11%
2010-12-31NZ$7.04 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
NZ$209.07 B-17.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$194.90 B-23.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$151.78 B-40.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$23.93 B-90.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$68.01 B-73.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$118.18 B-53.64%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$118.35 B-53.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$127.91 B-49.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
NZ$3.01 B-98.82%๐Ÿ‡บ๐Ÿ‡ธ USA